Charleston, SC -- (SBWIRE) -- 10/02/2013 -- Today’s Penny Stocks wants you, the investor, to have the ability to be informed in your trading decisions. Our website is designed to take you to the information you need to be at the top of your game in trading penny stocks. Today’s Penny Stocks issues news updates on the following stock: McDermott International (NYSE:MDR), Hercules Offshore, Inc. (NASDAQ:HERO), BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX), Standard Pacific Corp. (NYSE:SPF).
McDermott International (NYSE:MDR) ended its recent business day with the gain of 1.08% and closed at the price of $7.51 after opening at $7.40. The stock traded during its last trading session with the total volume of 2,827,259 shares, as compared to its average volume of 3.71 million shares. McDermott International, Inc. (MII) is a engineering, procurement, construction and installation (EPCI) company. The Company is focused on designing and executing complex offshore oil and gas projects worldwide. The Company provides fully integrated EPCI services.
For How Long MDR will Fight for Profitability? Read This Trend Analysis report
Hercules Offshore, Inc. (NASDAQ:HERO) remained among the day advancers and traded with volume of 2,661,047 shares in the last session, as compared to average volume of 2.12 million shares. In comparison with 52 week range of $4.36 - $7.96, it faced lowest price of $7.24 during the last trading session whereas its day highest price was $7.54. The company’s total market capitalization is $1.20 billion, along with 159.74 million shares outstanding.
For How Long HERO’s Gloss will Attract Investors? Find out via this report
BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) showed 1,611,677 shares in volume during the last trading session, while the average trading volume remained 1.53 million shares. The stock kicked off its trading session at $7.28 and closed at $7.60 after mounting 4.40%. BioCryst Pharmaceuticals, Inc. (BioCryst) is a biotechnology company. BioCryst designs, optimizes and develops drugs that block enzymes involved in the pathogenesis of diseases. The Company focuses on therapeutic areas. Peramivir is its product, which is a neuraminidase inhibitor for the treatment of patients with influenza.
Will BCRX Continue To Move Higher? Find Out Here
Standard Pacific Corp. (NYSE:SPF) stock traded during its last trading session with the total traded volume of 2,549,816 shares versus its average volume of 4.76 million shares. The company opened its trade at the price of $7.90 and its closing price was $8.05 after gaining 1.77% for the day. Standard Pacific Corp. is a geographically diversified business spans many of the housing markets, including metropolitan markets in California, Florida, the Carolinas, Texas, Arizona, and Colorado. The Company operates in two principal businesses: homebuilding and financial services (consisting of its mortgage financing and title operations).
Why Should Investors Buy SPF After The Recent Gain? Just Go Here and Find Out
About Today’s Penny Stocks:
Today’s Penny Stocks wants you, the investor, to have the ability to be informed in your trading decisions. Our website is designed to take you to the information you need to be at the top of your game in trading penny stocks. Today’s wants you to do your own due diligence on your investments please use our site to find the information you need on whichever investment you choose.
The disclaimer is to be read and fully understood before using our site, or joining our newsletter email list. Never invest into a stock discussed on this web site or the TodaysPennyStocks.com newsletter unless you can afford to lose your entire investment.
Please consult with a certified financial advisor before making any investment decisions.
TodaysPennyStocks.com is owned and operated by FlipVentures LLC. We are engaged in the business of advertising and promoting companies for monetary compensation. All content in our releases is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Neither the information presented nor any statement or expression of opinion, or any other matter herein, directly or indirectly constitutes a solicitation of the purchase or sale of any securities.
Read Full Disclaimer at: http://todayspennystocks.com/disclaimer/
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)